These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Overexpression of mitochondrial oxodicarboxylate carrier (ODC1) preserves oxidative phosphorylation in a yeast model of Barth syndrome. de Taffin de Tilques M; Tribouillard-Tanvier D; Tétaud E; Testet E; di Rago JP; Lasserre JP Dis Model Mech; 2017 Apr; 10(4):439-450. PubMed ID: 28188263 [TBL] [Abstract][Full Text] [Related]
44. Decreased pyruvate dehydrogenase activity in Tafazzin-deficient cells is caused by dysregulation of pyruvate dehydrogenase phosphatase 1 (PDP1). Liang Z; Ralph-Epps T; Schmidtke MW; Kumar V; Greenberg ML J Biol Chem; 2024 Mar; 300(3):105697. PubMed ID: 38301889 [TBL] [Abstract][Full Text] [Related]
45. Characterization of a transgenic short hairpin RNA-induced murine model of Tafazzin deficiency. Soustek MS; Falk DJ; Mah CS; Toth MJ; Schlame M; Lewin AS; Byrne BJ Hum Gene Ther; 2011 Jul; 22(7):865-71. PubMed ID: 21091282 [TBL] [Abstract][Full Text] [Related]
46. AAV-Mediated TAZ Gene Replacement Restores Mitochondrial and Cardioskeletal Function in Barth Syndrome. Suzuki-Hatano S; Saha M; Rizzo SA; Witko RL; Gosiker BJ; Ramanathan M; Soustek MS; Jones MD; Kang PB; Byrne BJ; Cade WT; Pacak CA Hum Gene Ther; 2019 Feb; 30(2):139-154. PubMed ID: 30070157 [TBL] [Abstract][Full Text] [Related]
47. Aberrant cardiolipin metabolism in the yeast taz1 mutant: a model for Barth syndrome. Gu Z; Valianpour F; Chen S; Vaz FM; Hakkaart GA; Wanders RJ; Greenberg ML Mol Microbiol; 2004 Jan; 51(1):149-58. PubMed ID: 14651618 [TBL] [Abstract][Full Text] [Related]
48. TAZ encodes tafazzin, a transacylase essential for cardiolipin formation and central to the etiology of Barth syndrome. Garlid AO; Schaffer CT; Kim J; Bhatt H; Guevara-Gonzalez V; Ping P Gene; 2020 Feb; 726():144148. PubMed ID: 31647997 [TBL] [Abstract][Full Text] [Related]
49. Cardiolipin deficiency affects respiratory chain function and organization in an induced pluripotent stem cell model of Barth syndrome. Dudek J; Cheng IF; Balleininger M; Vaz FM; Streckfuss-Bömeke K; Hübscher D; Vukotic M; Wanders RJ; Rehling P; Guan K Stem Cell Res; 2013 Sep; 11(2):806-19. PubMed ID: 23792436 [TBL] [Abstract][Full Text] [Related]
51. Deletion of the cardiolipin-specific phospholipase Cld1 rescues growth and life span defects in the tafazzin mutant: implications for Barth syndrome. Ye C; Lou W; Li Y; Chatzispyrou IA; Hüttemann M; Lee I; Houtkooper RH; Vaz FM; Chen S; Greenberg ML J Biol Chem; 2014 Feb; 289(6):3114-25. PubMed ID: 24318983 [TBL] [Abstract][Full Text] [Related]
52. Characterization of lymphoblast mitochondria from patients with Barth syndrome. Xu Y; Sutachan JJ; Plesken H; Kelley RI; Schlame M Lab Invest; 2005 Jun; 85(6):823-30. PubMed ID: 15806137 [TBL] [Abstract][Full Text] [Related]
54. Promotion of plasmalogen biosynthesis reverse lipid changes in a Barth Syndrome cell model. Bozelli JC; Lu D; Atilla-Gokcumen GE; Epand RM Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Jun; 1865(6):158677. PubMed ID: 32126285 [TBL] [Abstract][Full Text] [Related]
55. Hypogammaglobulinaemia and B cell lymphopaenia in Barth syndrome. Kudlaty E; Agnihotri N; Khojah A BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35732368 [TBL] [Abstract][Full Text] [Related]
56. Targeted overexpression of catalase to mitochondria does not prevent cardioskeletal myopathy in Barth syndrome. Johnson JM; Ferrara PJ; Verkerke ARP; Coleman CB; Wentzler EJ; Neufer PD; Kew KA; de Castro Brás LE; Funai K J Mol Cell Cardiol; 2018 Aug; 121():94-102. PubMed ID: 30008435 [TBL] [Abstract][Full Text] [Related]
57. Phospholipid abnormalities in children with Barth syndrome. Schlame M; Kelley RI; Feigenbaum A; Towbin JA; Heerdt PM; Schieble T; Wanders RJ; DiMauro S; Blanck TJ J Am Coll Cardiol; 2003 Dec; 42(11):1994-9. PubMed ID: 14662265 [TBL] [Abstract][Full Text] [Related]
58. Unremodeled and remodeled cardiolipin are functionally indistinguishable in yeast. Baile MG; Sathappa M; Lu YW; Pryce E; Whited K; McCaffery JM; Han X; Alder NN; Claypool SM J Biol Chem; 2014 Jan; 289(3):1768-78. PubMed ID: 24285538 [TBL] [Abstract][Full Text] [Related]
59. Phosphokinome Analysis of Barth Syndrome Lymphoblasts Identify Novel Targets in the Pathophysiology of the Disease. Agarwal P; Cole LK; Chandrakumar A; Hauff KD; Ravandi A; Dolinsky VW; Hatch GM Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30002286 [TBL] [Abstract][Full Text] [Related]
60. A novel TAZ gene mutation and mosaicism in a Polish family with Barth syndrome. Zapała B; Płatek T; Wybrańska I Ann Hum Genet; 2015 May; 79(3):218-24. PubMed ID: 25776009 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]